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ABSTRACT  
The circadian clock system instructs 24-hour rhythmicity on gene expression in 
essentially all cells, including adipocytes, and epigenetic mechanisms may participate in 
this regulation. The aim of this research was to investigate the influence of obesity and 
metabolic syndrome features in clock gene methylation and the involvement of these 
epigenetic modifications in the outcomes. Sixty normal-weight, overweight and obese 
women followed a 16-weeks weight reduction program. DNA methylation levels at 
different CpG sites of CLOCK, BMAL1 and PER2 genes were analyzed by Sequenom's 
MassARRAY in white blood cells obtained before the treatment. Statistical differences 
between normal-weight and overweight+obese subjects were found in the methylation 
status of different CpG sites of CLOCK (CpGs 1, 5-6, 8 and 11-14) and, with lower 
statistical significance, in BMAL1 (CpGs 6-7, 8, 15 and 16-17). The methylation pattern 
of different CpG sites of the three genes showed significant associations with 
anthropometric parameters such as BMI and adiposity, and with a metabolic syndrome 
score. Moreover, the baseline methylation levels of CLOCK CpG 1 and PER2 CpGs 2-3 
and 25 correlated with the magnitude of weight loss. Interestingly, the percentage of 
methylation of CLOCK CpGs 1 and 8 showed associations with the intake of 
monounsaturated and polyunsaturated fatty acids. This study demonstrates for the first 
time an association between methylation status of CpG sites located in clock genes 
(CLOCK, BMAL1 and PER2) with obesity, metabolic syndrome and weight loss. 
Moreover, the methylation status of different CpG sites in CLOCK and PER2 could be 
used as biomarkers of weight loss success, particularly CLOCK CPGs 5-6. 
Keywords: Epigenetics, MUFA, cytosine methylation, MassARRAY, biomarker
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INTRODUCTION 
The interaction between poor dietary habits and lifestyles with genetic traits is crucial in 
the development of obesity and metabolic syndrome (MetS) (Garaulet et al., 2010a). 
However, other putative causal factors contributing to excessive fat accumulation have 
been recently proposed, which includes sleep duration and quality and epigenetics, 
among others (McAllister et al., 2009). 
Concerning the first one, it has been reported that patients with visceral obesity and 
MetS exhibit disturbances in the circadian rhythm (chronodisruption) that may be 
associated with higher weight increase and development of diabetes and atherosclerotic 
disease (Gómez-Santos et al., 2009; Cardinali et al., 2011). Thus, experimental studies 
have shown that prolonged short sleep durations could increase appetite, compromise 
insulin sensitivity and raise blood pressure, being probably involved in the development 
of metabolic disorders, such as obesity, diabetes and hypertension (Gangwisch, 2009). 
Regarding the second one, in the last years, epigenetic phenomena and intergenerational 
effects have been considered as potential contributors to the obesity epidemic, in some 
cases associated to the developmental origin of health and disease (DOHaD) hypothesis 
(Wadhwa et al., 2009). Cytosine DNA methylation, the most studied epigenetic 
mechanism, is usually considered a flexible method for repressing gene expression. 
Different dietary and lifestyle factors are able to modulate the methylation of specific 
CpG sites in gene promoters even in the adult age (Campion et al., 2010). In relation to 
obesity, the percentage of methylation of specific CpG sites in blood cells is being 
investigated as a potential predictor of weight loss response (Milagro et al., 2011) or as 
a personalized signature of obesity (Feinberg et al., 2010). In this way, peripheral blood 
DNA from Italian subjects working in chemical plants has been used to study the effects 
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of shiftwork exposure on DNA methylation (Bollati et al., 2010). In this study, different 
factors such as job seniority, length of shiftwork, and morning and evening types were 
associated with the methylation of the promoters of glucocorticoid receptor, TNF-alpha, 
and IFN-gamma. 
With respect to clock genes, a recent study (Zhu et al., 2011) has reported that long-term 
shiftwork, previously related to obesity and MetS risk (Manenschijn et al., 2011), 
induces hypomethylation in the promoter of CLOCK gene and hypermethylation of 
CRY2 in peripheral blood DNA. In this context, a relationship between clock genes and 
obesity has been suggested from the analysis of BMAL1 and CLOCK mutant mice. 
Thus, CLOCK mutant mice are hyperphagic and obese, and develop a metabolic 
syndrome of hyperleptinemia, hyperlipidemia, hepatic steatosis, hyperglycemia, and 
hypoinsulinemia (Turek et al., 2005), whereas BMAL1 null animals show changes in 
glucose homeostasis (Rudic et al., 2004) as well as dyslipidemia and ectopic fat 
accumulation in liver and skeletal muscle (Shimba et al., 2011). In fact, both models 
show reduced insulin secretion, impaired glucose tolerance, and defects in proliferation 
and size of pancreatic islets that lead to diabetes (Marcheva et al., 2010). Moreover, 
genetic variations (SNPs) in some of the clock genes, such as PER2 (Garaulet et al., 
2010b) and CLOCK (Garaulet et al., 2011b), have been related with caloric intake, 
circulating cytokine and ghrelin levels, eating behavior and attrition in weight-loss 
treatments. These data suggest that a relationship between clock gene dysregulation and 
obesity and MetS may exist. 
Another point of interest is the possible involvement of fatty acids in the methylation 
process and in the regulation of the expression of clock genes. The latter has been 
recently demonstrated by Fick et al. (2011) when culturing immortalized, hypothalamic 
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neurons with palmitate. However, to date, no study in humans (i.e., intervention studies) 
has obtained evidence for a direct involvement of fatty acids on DNA methylation 
regulation. Nevertheless, some in vitro studies suggest that monounsaturated and 
polyunsaturated fatty acids could play a role in this epigenetic mechanism, particularly 
n-3 PUFA (Kulkarni et al., 2011; Ceccarelli et al., 2011). 
The aim of this research was to investigate the influence of obesity and MetS features in 
clock gene methylation and the description of some epigenetic modifications in clock 
genes that could be used as predictors of weight loss success. Additionally, we look for 
dietary and life style factors that could be related to the methylation of these genes in 
white cells and that could interrelate with circadian clock alterations, environmental 
factors and obesity development. 
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 METHODS 
Subjects and Methods 
We recruited normal-weight (n=20), overweight/obese (n=20) and morbidly 
obese women (n=20) (BMI<25 kg/m2, 29-35 kg/m2 and >40 kg/m2, respectively) within 
the age range of 25–53 years (total n=60) who attended five outpatient obesity clinics 
during 2009-2010 in the city of Murcia, southeastern Spain. Those patients who were 
out of this range of age, under treatment with thermogenic or lipogenic drugs, on a 
special diet, or diagnosed with diabetes mellitus, chronic renal failure, hepatic diseases 
or cancer were excluded from the study (9%). All clinical investigations described in 
this manuscript have been conducted in accordance with the guidelines in the 
Declaration of Helsinki. Written consent was obtained from each patient before 
participation and the study principles were approved by the Research Ethics Committee 
of the Virgen de la Arrixaca Hospital. Patient data were codified to guarantee 
anonymity. The experimental protocol is conform to international ethical standards 
(Portaluppi et al., 2010). Figure 1 shows the intervention protocol carried out.  
 
Characteristics of the Treatment 
The characteristics of the weight reduction program (Garaulet method©) have 
been described elsewhere (Corbalan et al., 2009) and are represented in Figure 1. 
Briefly, during the initial 4 months, subjects attended a weekly 60-min therapy session 
in support groups (n=10), followed by a 5-month maintenance period. Sessions were 
conducted by a nutritionist. Treatment was based on the following issues:  
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The energy requirements were calculated using the Harris-Benedict formula and, 
according to the type of physical activity, were decreased to about 2.6MJ/day so as to 
induce an approximate loss of between 0.5 and 1kg/week. A Mediterranean-type diet 
was followed, with the distribution of the principal components as recommended by the 
Spanish Society of Community Nutrition (Serra-Majem et al., 2001): 35% fat (<10% 
saturated and 20% monounsaturated), 50% carbohydrates and 15% to 20% of proteins. 
Patients were advised to consume unlimited amount of vegetables with a minimum of 
200g per day, at least 250 to 300 g of fruits daily and olive oil as the only cooking fat. 
They were also encouraged to consume the following foods for lunch: at least 100 g of 
legumes three times a week, 100 g rice once a week, 100 g wheat and pasta once a 
week, and at least one day of fish per week. Total cholesterol intake was recommended 
to be below 300 mg, and fiber intake was higher to 15 g per day. Patients were also 
rewarded with extra calories (optional calories) and extra food interchanges (floating 
portions) for special occasions. 
During the group therapy, sessions were classified into four types: 1) Nutrition-
based sessions, to help choose the food for the dietary record. 2) Physiological-based 
sessions, to help explain body weight regulatory mechanisms, processes of nutrient 
absorption and digestion and the physiology of weight loss. 3) Behavioral and cognitive 
sessions, which help the patient to control stimuli, avoid negative thoughts or detect the 
main obstacles to weight loss; and 4) Practical ideas, to help to organize outings, 
shopping lists, alternatives to dinner, the importance of breakfast, etc. Every week the 
sessions explained one simple recipe. 
Individualized long-term goals were established to accumulate at least 30 
minutes or more of moderate-intensity physical activity on most, and preferably, all 
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days of the week, unless medically contraindicated. Patients were stimulated to fulfill 
these recommendations with the use of a pedometer, incentivizing them to reach at least 
10.000 steps per day. 
Different behavioral techniques were included: Stimulus control, referring to 
how the immediate environment can be altered to promote behaviors that help weight 
loss; Self-monitoring, considered as one of the principal pillars of the treatment and 
referring to keep a daily record of food consumed and physical exercise; Positive 
reinforcement, patients being rewarded with incentives not related with food, such as a 
small gifts, prizes or diplomas when the aimed-for weight goal was reached; and 
Preventing relapses, by teaching how to identify “slips”. 
 
Habitual Dietary Intake 
To evaluate food habits, the initial nutrient intake was determined by a 24-h 
dietary recall. Interviews were conducted from Monday to Friday, including 24-h recalls 
of food intake from weekends and weekdays. Total energy intake and macronutrient 
composition from the initial 24-h recalls were analyzed with the nutritional evaluation 
software program Grunumur (Perez-Llamas et al., 2004), based on Spanish food 
composition tables (Moreiras et al., 2009). The intakes of the main saturated fatty acids, 
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), 
including linoleic [18:2(n-6)], linolenic [18:3(n-6)], eicosapentaenoic [20:5(n-3)], and 
docosahexaenoic [22:6(n-3)] acids, were also calculated from Spanish food-composition 
tables (Moreiras et al., 2009). 
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Chronodisruptors 
Sleep duration: Habitual sleep time was estimated by a questionnaire containing the 
following questions: ‘During week days: How many hours (and minutes) do you usually 
sleep? and; ‘During weekend days: How many hours (and minutes) do you usually 
sleep? A total weekly sleep score was calculated as: ((min Weekdays x 5) + (min 
Weekend days x 2))/7 (Garaulet et al. 2011a). 
Snacking frequency and different eating behaviors were assessed by a behavioral data 
checklist (Corbalan et al., 2009). Logistic regression models were fitted to estimate the 
risk of a specific behavior associated with high or low methylation levels in the 
different clock genes studied, which were dichotomized according to the median value 
of the population. 
Eveningness was assessed by the Horne and Ostberg questionnaire to assess 
morningness–eveningness (Horne & Ostberg, 1976). This questionnaire establishes five 
behavioral categories: definitively morning types (score = 70-86), moderately morning 
types (score = 59-69), neither types (score = 42-58), moderately evening types (score = 
31-41), definitively evening types (score = 16-30).  
Anthropometric Measurements and Blood Pressure  
Subjects were weighed barefoot wearing light clothes, with a digital scale to the 
nearest 0.1 kg, at the same time each day weekly to assess weight loss during treatment. 
Height was measured using a Harpenden digital stadiometer (rank 0.70–2.05). The 
subject was positioned upright, relaxed and with the head in the Frankfurt plane. BMI 
was calculated as weight (kg)/(height(m))2. Total body fat was measured by 
bioelectrical impedance using TANITA TBF-300 (TANITA Corporation of America, 
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Arlington Heights, IL, USA) equipment. Body fat distribution was assessed by the 
measurement of different circumferences: waist circumference, at the level of the 
umbilicus. All measurements were made with a flexible and inextensible tape measure. 
Blood pressure was measured seated with arm resting on a table following WHO 
criteria and recorded as millimeters of mercury (mm Hg). 
 
Biochemical and Endocrine Variables 
Plasma glucose, cholesterol, triglycerides (TG) and lipoprotein concentrations 
were determined by an automated chemical analysis. VLDL-cholesterol (VLDL-C) (d< 
1.006•10-3 g/L) was prepared by ultracentrifugation (Havel et al., 1955). HDL-
cholesterol (HDL-C) was measured after precipitation of apoB-containing lipoproteins 
with dextran sulfate and magnesium (Warnick et al., 1982). LDL cholesterol (LDL-C) 
was calculated as total cholesterol (TC) minus HDL-C plus VLDL-C using the 
Friedewald equation when TG concentration was < 4.52 mmol/L. 
Plasma ghrelin levels at baseline were measured by radioimmunoassay (Linco 
Research, St. Charles, MO). Serum insulin at baseline was measured by 
radioimmunoassay (Coat A Count Insulin, DCP) (assay precision: CV <10% at 16 
µU/mL concentration, cross reactivity with proinsulin=20%). Indexes of insulin 
resistance for the homeostasis model assessment (HOMA IR = fasting glucose 
(mmol/L) × fasting insulin (μIU/L)/22.5) and insulin sensitivity (QUICKI = 1/log 
fasting insulin + log glycemia in mg/dL) were calculated with validated formulae. 
We used IDF consensus 2006 definition (Alberti et al., 2005) to classify patients 
for MetS, which was defined by the presence of central obesity (waist circumference > 
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88 cm) and 2 or more of the following characteristics: Raised triglycerides (TG ≥ 150 
mg/dL, 1.7 mmol/L), low HDL-C (HDL-C < 1.29 mmol/L, 50 mg/dL), hypertension 
(blood pressure ≥ 130/85 mm Hg or taking medication), and elevated fasting plasma 
glucose (basal glycemia ≥ 110 mg/dL, 6.1 mmol/L) and a MetS score was calculated. 
 
DNA Methylation Analysis 
White blood cells were obtained before the treatment. Genomic DNA was 
isolated from white blood cells (QIAamp DNA Mini KIT, Qiagen Gmbh, Hilden, 
Germany) and was sodium bisulfite-converted (EZ-96 DNA Methylation Kit, Zymo 
Research Co., Orange, CA, USA). Sequenom's MassARRAY platform was used to 
perform quantitative methylation analysis. This system utilizes MALDI-TOF mass 
spectrometry in combination with RNA base specific cleavage (MassCLEAVE). PCR 
primers covering four relevant regions (Figure 2) of the three following genes, CLOCK 
(2 regions selected from the NCBI Reference Sequence NC_000004.11), BMAL1 (from 
NC_000011.9) and PER2 (from NG_012146.1), were designed using Epidesigner 
software (Bruker–Sequenom, San Diego, CA, USA). The primers used were: 
For CLOCK-R1 (271 bp length): Left, TTTTTTTAGGAGATGGGAGAAGATG, 
 Right, CCTAAAAACT CTTTAACTTTCCCCC; 
For CLOCK-R2 (399 bp length): Left, GTTTTTGGGTTGGTGGAGGA, 
 Right, CCAAAAAACCTCTCAAACAAAAC; 
For BMAL1 (376 bp length): Left, TGAGATTTTGGTAAATTAGGGATTTT, 
 Right, ACTACTTTCCTACCACCAATCATTTAAC; 
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For PER2 (430 bp length): Left, AAACTTCCTTATCCCTCTAATCACC, 
 Right, GTGTGTTTTTGGTTTTGTTTTAGGT. 
Genomic DNA position (Assembly GRCh37/hg19) of targeted CpGs and the 
sequence of the amplicons (in which the analyzed CpGs are highlighted) are shown in 
Figure 2. The complete methodology, including PCR and MassCLEAVE biochemistry, 
has been previously described (Milagro et al., 2011). Mass spectra were collected using 
a MassARRAY mass spectrometer (Bruker–Sequenom) and subsequently analyzed 
using proprietary peak picking and signal-to-noise calculations by using Epityper 
software v1.0 (Bruker–Sequenom). 
 
Statistical Analysis 
Clinical and anthropometric data are presented as means ± SD. The results of 
CpG methylation, expressed as the ratio of methylated versus total cytosines, are 
presented as means ± SEM. When the three groups were compared, one-way analysis of 
variance (ANOVA) followed by Tukey's post hoc test was used. When the 
overweight/obese and morbidly obese individuals were grouped (overweight+obese 
group), Student's t-test was used to analyze the differences with the normal-weight 
group. 
Pearson’s correlation coefficients were used for analyzing associations between 
the percentages of cytosine methylation in several CpGs of clock genes and obesity 
characteristics, MetS traits, weight loss and fatty acids in the diet. The analysis of 
correlation was repeated adjusting for BMI. All statistical analyses were carried out 
using SPSS for windows 15.0 (SPSS Inc, Chicago, IL). The level of significance for all 
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statistical tests and hypotheses was set at P<0.05, although trends towards significance 
(0.1>p>0.05) have been highlighted in the tables. 
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RESULTS 
Demographic, nutritional, anthropometric and biochemical characteristics of the 
studied population are shown in Table 1. According to the Horne and Ostberg 
questionnaire, all women had the same chronotype. 
The Sequenom’s MassArray analysis of DNA methylation revealed differences 
between normal-weight, overweight/obese and morbidly obese women in different 
CpGs of CLOCK and BMAL1 genes. As no differences were noted between both 
overweight/obese and morbidly obese groups for any CpG analyzed, both groups were 
combined (overweight+obese group) and together compared with the normal-weight 
subjects. Our analysis of these two groups showed statistically significant differences in 
the CLOCK gene, especially in CpG 1 (2.4% in obese subjects versus 1.1% in normal-
weight), CpGs 5-6 (17.4% versus 12.4%) and CpG8 (10.8% versus 8.7%) with the pair 
of primers R1 (Figure 3, Supplementary Table 1A), and CpGs 11-14 with the pair of 
primers R2 (Figure 3, Supplementary Table 1B). 
In the case of BMAL1 cytosine methylation levels, negligible differences were 
observed between the three groups (Supplementary Table 1D). However, statistically 
significant differences were found when comparing overweight+obese individuals and 
normal-weight subjects in CpGs 6-7, 8, 15 and 16-17 (Supplementary Figure 1). 
Finally, no differences were observed in PER2 cytosine methylation levels when 
comparing the two groups, normal-weight and overweight+obese subjects 
(Supplementary Table 1C). 
The methylation patterns of different CLOCK CpGs showed close associations 
among them (Supplementary Figure 2), suggesting that they share a common regulation. 
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Similar associations were observed when the methylation levels of several CpGs of 
BMAL1 (Supplementary Figure 2). 
 Overall, the three genes studied showed significant and positive associations 
between obesity characteristics and the CpG methylation levels. This was especially the 
case of the methylation levels of CLOCK CpGs 5-6, PER2 CpGs 2-3 and CpG 25, and 
BMAL1 CpGs 16-17. With respect to CLOCK gene methylation, BMI and waist 
circumference were associated with CpGs 1 and 5-6, whereas body fat was associated 
with CpGs 5-6, 11, 12-13 and 14 (Table 2A). On the other hand, BMAL1 CpG 16-17 
was associated with body fat whereas PER2 CpGs 2-3 and 25 showed association with 
BMI (Tables 2C and 2D). These results suggest that the methylation levels of these 
CpGs in blood cells could be conjointly regulated by adiposity and fat mass, or that 
some common factors could influence the methylation levels of all these CpG sites. 
Tables 2A, 2B and 2C show also the correlations between DNA methylation at 
the three clock genes and MetS characteristics. In the case of the first region of CLOCK 
gene promoter (CPGs 1, 5-6 and 8), methylation levels were positively associated with 
waist circumference, serum glucose and triglyceride levels, blood pressure, HOMA 
index, and the MetS score, but negatively associated with circulating adiponectin. A 
similar situation was found for PER2 and BMAL1, whose methylation levels were 
positively associated with MetS risk. In most cases, the significance of the correlations 
between MetS variables and cytosine methylation levels was maintained after adjusting 
for BMI (data not shown). 
Of note, different chronodisruptors were related to methylation levels. For 
example, sleep duration was inversely correlated to the methylation levels of CLOCK 
CpG 1 after adjusting for obesity parameters and physical activity (r=-0.45; P=0.020). 
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Another important circadian synchronizer is food intake (Garaulet & Madrid, 2010). In 
this sense, eating behaviors, such as a high frequency of snacking, eating quickly, eating 
when bored or eating from big packages, were all positively associated to the 
methylation levels of CLOCK CpG 1 (Table 3), and the same trend was found for the 
other genes although statistical significance was not reached (P>0.05). The orexigenic 
hormone ghrelin could be influencing these results, since the methylation levels of 
CLOCK CpG 1 were significantly and positively correlated to morning fasting ghrelin 
plasma levels (r=0.463; P=0.035). 
Morningness-eveningness score also tended to correlate inversely to CLOCK 
CPG 1 methylation levels, which would indicate that there is a tendency to eveningness 
with higher methylation levels, although statistical significance was not reached 
(r=0.274   P=0.072). 
Dietary intake could also be influencing the significant associations between 
DNA methylation and MetS features. Indeed, in this Mediterranean population 
characterized by a high intake of olive oil and MUFA, the methylation levels of CLOCK 
CpGs 1 and 8 were negatively associated with MUFA intake (P<0.05) while the 
association was positive with PUFA (P<0.05) (Figure 4). These results suggest that 
fatty acid composition of the diet could influence the methylation pattern of genes 
involved in circadian rhythm regulation.  
Finally, the association between weight loss and the baseline methylation levels 
of CLOCK CpG 1, PER2 CpG 2-3 and PER2 CpG 25 (Table 4) suggests that these 
epigenetic marks could be used as markers of weight loss.
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DISCUSSION 
This research has identified novel associations between methylation patterns at 
circadian clock genes and MetS factors. It also suggests that some of these CpGs could 
be used as biomarkers of weight loss response, although these results should be 
validated in new and larger populations. Different chronodisruptors such as sleep 
curtailment, frequent snacking or eating quickly, and endocrine parameters, such as 
ghrelin plasma levels were also associated to changes in the methylation pattern. 
However, due to the nature of the experiment performed, it is not possible to elucidate 
whether these epigenetic changes in the clock genes are cause or effects of obesity. In 
addition, our data point out, for the first time, that dietary intake of MUFA and PUFA 
could affect the methylation levels of some cytosines, maybe contributing to modulate 
clock gene expression. 
Recent studies have reported that the methylation status of the promoters at several 
human clock genes is altered in diseases like cancer (Shih et al., 2006). Also, the 
methylation status of CpGs located in the promoter of some genes has been related to 
obesity and its comorbidities. Thus, a recent report has evidenced that the methylation 
of different gene promoters (RXRA, eNOS) at birth is associated with child's later 
adiposity (Godfrey et al., 2011), suggesting that prenatal developmental may alter the 
epigenetic regulation of key components of metabolic disease risk. According to this, a 
perinatal epigenetic analysis might identify subjects at high risk of developing later 
obesity (Lillycrop & Burdge, 2011). In relation to the clock genes, Suter et al. (2011) 
have found that in utero exposure to a maternal high-fat diet significantly alters NPAS2 
promoter occupancy of acetylation of fetal histone H3 at lysine 14 (H3K14ac), a paralog 
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of the CLOCK transcription factor, affecting thus the peripheral circadian system of the 
fetus. 
One important issue is that not only prenatal developmental, but also several factors 
during adulthood, may alter the epigenetic regulation of metabolic disease risk factors. 
Thus, obesity per se, but also diet composition, inflammation and oxidative stress, 
which are usually exacerbated in obese adipose tissue, may contribute to alter the 
epigenetic pattern (Campión et al., 2010). In the current study, although some of the 
differences between overweight+obese and normal-weight women could be due to 
perinatal factors or to life style differences, including diet, it is reasonable to assume 
that obesity itself could be a causative factor of these differences. In fact, the close 
direct associations found between methylation of several CpGs of CLOCK gene and 
waist circumference, serum glucose and triglyceride levels, blood pressure, HOMA 
index and the MetS score, as well as the inverse association with circulating 
adiponectin, together with other results obtained with BMAL1 and PER2 genes, strongly 
suggest that some of these factors could affect the methylation pattern of  clock genes or 
even that this methylation could be a causative factor of obesity and MetS. As in the 
current study we did not have enough tissue for performing gene expression analyses, 
new studies must be designed to demonstrate whether methylation in these areas alter 
mRNA expression in white blood cells. With the exception of CpGs 11-14, the trend of 
CLOCK gene is to increase its methylation levels. According to the traditional view, an 
increase in methylation would induce a decrease of clock gene expression in white cells. 
However, the physiological or metabolic consequences of this lower expression of 
CLOCK in these cells remain unknown. Although usually almost all the CpGs of a near 
region responds in a similar way to an epigenetic factor, in our experiment, CpGs 11-14, 
which are located in the first intron of CLOCK gene, responded in an opposite way than 
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the promoter. Sometimes this phenomenon is explained because these CpGs overlap 
with a transcription factor binding site that inhibits the transcription of the gene, but we 
have not found in our sequence a clear correspondence with an inhibitory transcription 
factor close to the CpGs 11-14. 
Our group has previously reported significant associations between clock genes and 
MetS alterations. For example, we have confirmed that PER2 expression in human 
visceral AT was negatively correlated with waist circumference in men (Gómez-
Abellán et al., 2008) and with MetS risk in women (Hernandez-Morante et al., 2011). 
We have also demonstrated that a genetic variant in human PER2 has been linked to 
abdominal obesity and to alterations in eating behaviors highly associated with obesity 
(Garaulet et al., 2010b). On the other hand, a number of CLOCK SNPs have been 
correlated with predisposition to MetS (Sookoian et al., 2008). In our study, the 
methylation levels of CLOCK CPGs 5-6 show the strongest correlations with MetS 
features (including BMI and body fat, HOMA index and systolic pressure). In order to 
confirm this, more studies are required, including a larger sample size, male subjects 
and the application of multiple testing corrections. Even, methylation of CPGs 5-6 
could be analyzed in other cell types, such as adipose tissue, which are more typically 
involved in obesity and its metabolic sequellae. As a final objective, RNA should be 
obtained from the same biological samples to assess whether methylation in these areas 
alter mRNA expression. 
Other interesting result obtained in the current population is the particular association 
between clock gene methylation levels and weight loss. In this sense, recent studies 
have reported that the percentage of methylation in different CpGs of genes involved in 
energy metabolism could be used as biomarkers of weight loss response. Thus, by using 
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methylation microarray analysis at baseline, Bouchard et al. found differences at 35 loci 
when comparing subcutaneous adipose tissue biopsy samples from high and low 
responders to a 6-month caloric restriction intervention (Bouchard et al., 2010), whereas 
Milagro et al. (2011) observed 432 CpG sites hypomethylated (<20%) and 602 
hypermethylated (>20%) in the peripheral blood mononuclear cells from high 
responders to an 8-week caloric restriction intervention when compared with the low 
responders. These initial findings strongly suggest that baseline DNA methylation 
patterns in white blood cells may be used as epigenetic markers that might help to 
predict and personalize weight loss. In our case, the baseline methylation levels of 
CLOCK CpG 1, PER2 CpG 2-3 and PER2 CpG 25, which showed a correlation with 
weight loss during the treatment, could be studied for this purpose. These results 
reinforce a previous work demonstrating the usefulness of some CLOCK gene variants 
in the prediction of weight loss (Garaulet et al., 2010a). 
This report is the first demonstrating that epigenetic mechanisms related to cytosine 
methylation in clock gene promoters might be involved in the onset of obesity and 
MetS. However, more studies should be accomplished to determine if the methylation 
of these cytosines has any functional significance for gene expression. Different 
chronobiological characteristics, such as sleep deprivation, frequent snacking, nocturnal 
eating and bright light exposure at night (Garaulet et al., 2010a), are recurrent in obesity 
and might influence the methylation levels of clock genes and vice versa.  Our data 
support this hypothesis taking into account that in the current population, sleep duration 
was inversely correlated to the methylation levels of CLOCK CpG 1, which suggests a 
functional role of CLOCK methylation levels on chornodisruption and, as a 
consequence, in obesity. In this sense, food intake, which is another important 
synchronizer particularly for the peripheral clocks, coordinating circadian rhythms of 
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behavior, peripheral clock gene expression and hormone secretion (Sheward et al., 
2007), has been also in our experiment related to methylation levels in CLOCK gene. 
Our data also indicate that patients who tended to snack frequently, to eat when bored or 
to eat from great packages had higher methylation levels in CLOCK CpG1 (P=0.026, 
P=0.008 and P=0.004, respectively). 
Ghrelin, which in our study has been also positively associated with methylation levels 
in CLOCK gene, could be implicated in these results. Ghrelin stimulates food intake and 
recent evidence suggests that ghrelin promotes sleep (Kotronoulas et al., 2009). All 
these results together support the notion that CLOCK methylation levels influence 
behaviors related to chronodisruption, such as sleep reduction, constant snacking and 
evening preference, as well as appetite regulators such as plasma ghrelin levels. Similar 
results have been previously demonstrated for CLOCK SNPs. For example, sleep 
reduction, changes in ghrelin values, alterations of eating behaviors and evening 
preference that characterize CLOCK 3111C carriers could be affecting obesity and 
weight loss (Garaulet et al., 2011b). In this sense, although not yet well known, 
melatonin, the major hormonal regulator of circadian rhythm, works via epigenetic 
processes through modulation of histone acetylation and DNA methylation (Korkmaz et 
al., 2009). 
Finally, an outstanding result of the current study is the association between the type of 
fatty acids in the diet (particularly MUFA and PUFA) and the methylation patterns in 
adults. Our group had previously reported that high-fat diets alter the methylation status 
of different gene promoters in rat adipose tissue, such as those of fatty acid synthase 
(FASN) and NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (NDUFB6) 
(Lomba et al., 2010). However, few studies (all of them in vitro) have evidenced the 
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role of n-3 and n-6 PUFA on DNA methylation, particularly docosahexaenoic (Kulkarni 
et al., 2011), eicosapentaenoic (Ceccarelli et al., 2011) and arachidonic (Kiec-Wilk et 
al., 2011) fatty acids. The diet of the women participating in the present study can be 
ascribed to a Mediterranean pattern, being rich in olive oil and, therefore, in MUFA. 
However, for the moment there are apparently no publications analyzing the effects of 
MUFA on DNA methylation. In a study performed in a Mediterranean population, we 
have recently demonstrated that CLOCK polymorphisms interact with fatty acids to 
modulate MetS traits. In that study, the dietary source and membrane content of 
MUFAs were implicated in the relations between alterations in the circadian system and 
MetS (Garaulet et al., 2009). 
In summary, our research unveils new epigenetic mechanisms involving clock genes 
that may contribute to better obesity prevention, as well as better prediction of 
successful weight reduction. Of note, these new data related to DNA methylation are 
consistent with previous results related to CLOCK genetic variants, which demonstrated 
that sleep reduction, changes in ghrelin values, alterations of eating behaviors and 
evening preference are all connecting genetics, chronodisruption and obesity. These 
results support the hypothesis that the influence of the clock genes may be extended to a 
broad range of variables linked with human behavior and metabolism. Moreover, our 
data pave the way to the study of epigenetic mechanisms in the regulation of circadian 
rhythms in relation to obesity and weight loss. 
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Table 1. Characteristics of the study population 
 
 
Table 2. Associations between the percentage of cytosine methylation in several CpG 
sites located in CLOCK gene and metabolic syndrome characteristics. r= Pearson 
correlation coefficient; P= Probability value (*P<0.05) 
 
Table 3. Association between eating behavior (high frequency of snacking, eating 
quickly, eating when bored, and eating from big packages) and presence of high 
methylation levels (> median) of CLOCK CpG 1.     
 
 
Table 4. Pearson´s correlations between CLOCK (CpG 1) and PER2 (CpG 2-3 and CpG 
25) methylation levels and weight loss. r= Pearson correlation coefficient; P= 
Probability value  
 
 
Supplementary table 1. Percentages of CpG methylation in the three groups (normal-
weight, overweight/obese and morbidly obese) measured by Sequenom´s 
MassARRAY®. Two regions of CLOCK gene were quantified (with the pairs of 
primers R1 and R2, Tables 1A and 1B respectively) but only one in the case of PER2 
(Table 1C) and BMAL1 (Table 1D). The data are the average percentage of CpG 
methylation ± SEM.
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Figure legends 
 
Figure 1. Intervention protocol of the study. 
 
Figure 2. Genomic DNA position of targeted CpGs and sequence of the amplicons. 
Two regions of CLOCK gene were quantified (with the pairs of primers R1 and R2) but 
only one in the case of BMAL1 and PER2. The vertical lines represent the CpGs present 
in the sequence. The numbered horizontal lines under the sequence represent the regions 
amplified by the PCR primers and shown below. Number on the left of each sequence 
file represents the position with respect to the start of transcription (ATG). CpGs are 
highlighted in bold and consecutively numbered in each sequence. Underlined CpGs are 
the sites that were reliably quantified by EpiTYPER; boxes in the sequence indicate that 
these CpGs could not be discriminated by EpiTYPER. 
 
Figure 3. Differences in the percentage of cytosine methylation in several CpGs of 
CLOCK gene between normal-weight and overweight+obese subjects. 
   
Figure 4. Partial correlations between the percentage of methylation of CLOCK CpG 1 
and CLOCK CpG 8 with the percentage of MUFA (3A) and PUFA (3B) in the diet, 
after adjusting total fat intake by the body mass index of each subject. 
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Supplementary Figure 1. Differences in the percentage of cytosine methylation in 
several CpGs of BMAL1 gene between normal-weight and overweight+obese subjects.   
 
Supplementary Figure 2. Associations between the percentage of cytosine methylation 
in several CpGs of CLOCK and BMAL1 genes. 
 
